Order Article Reprints

Eskazan T, Bakkaloglu OK, Durcan E, Akpinar A, Kurt EA, Onal U, Erzin YZ, Hatemi AI, Celik AF. Long-Term Oral Budesonide Use in Inflammatory Bowel Disease: Effects on Bone Mineral Density and Late-Onset Adverse Events. Diagnostics. 2025; 15(17):2271. https://doi.org/10.3390/diagnostics15172271

Eskazan, Tugce, Oguz Kagan Bakkaloglu, Emre Durcan, Atilla Akpinar, Enes Ali Kurt, Ugur Onal, Yusuf Ziya Erzin, Ali Ibrahim Hatemi, and Aykut Ferhat Celik. 2025. "Long-Term Oral Budesonide Use in Inflammatory Bowel Disease: Effects on Bone Mineral Density and Late-Onset Adverse Events" Diagnostics 15, no. 17: 2271. https://doi.org/10.3390/diagnostics15172271

Eskazan, T., Bakkaloglu, O. K., Durcan, E., Akpinar, A., Kurt, E. A., Onal, U., Erzin, Y. Z., Hatemi, A. I., & Celik, A. F. (2025). Long-Term Oral Budesonide Use in Inflammatory Bowel Disease: Effects on Bone Mineral Density and Late-Onset Adverse Events. Diagnostics, 15(17), 2271. https://doi.org/10.3390/diagnostics15172271